Iododoxorubicin is a derivative of Doxorubicin ( HY-15142A ) and anticancer agent. Iododoxorubicin has stronger activity against Lewis lung carcinoma than Doxorubicin .
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Lung Cancer | Products > Signaling Pathways > Others | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Drug Derivative
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.